Authors: Stanislao Rizzo, Pierre Olivier Barale, Sarah Ayello-Scheer, Robert G. Devenyi, Marie Noelle Delyfer, Jean-François Korobelnik, Aleksandra Rachitskaya, Alex Yuan, K. Thiran Jayasundera, David N. Zacks, James T. Handa, Sandra R. Montezuma, Dara D. Koozekanani, Paulo E. Stanga, Lyndon da Cruz, Peter Walter, Albert J. Augustin, Lisa C. Olmos de Koo, Allen C. Ho, Bernd Kirchhof, Paul Hahn, Lejla Vajzovic, Raymond Iezzi, David Gaucher, J. Fernando Arevalo, Ninel Z. Gregori, Peter Wiedemann, Emin Özmert, Jennifer I. Lim, Flavio A. Rezende, Suber S. Huang, Francesco Merlini, Uday Patel, Robert J. Greenberg, Sally Justus, Daniela Bacherini, Laura Cinelli, Mark S. Humayun
Venue: British Journal of Ophthalmology
Type: Publication
Abstract: The Argus II retinal prosthesis (Second Sight Medical Products, Sylmar, CA, USA) is an electronic epiretinal implant designed for use in patients with end-stage retinitis pigmentosa, as well as for other outer retinal degenerative conditions, such as choroideremia, Leber’s congenital amaurosis, Bardet-Biedl syndrome, Usher syndrome and rod–cone disease.1 This device was tested in a clinical trial of 30 subjects in the USA and in Europe to measure the rate of serious adverse events (SAEs) and to assess its effects on functional vision and vi...
(read more)
Topics: 
Ophthalmology
Surgery
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...